scispace - formally typeset
K

Kenneth Butcher

Researcher at University of New South Wales

Publications -  237
Citations -  11570

Kenneth Butcher is an academic researcher from University of New South Wales. The author has contributed to research in topics: Stroke & Intracerebral hemorrhage. The author has an hindex of 50, co-authored 221 publications receiving 9713 citations. Previous affiliations of Kenneth Butcher include Toronto Western Hospital & Macquarie University.

Papers
More filters
Journal ArticleDOI

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Stephen M. Davis, +20 more
- 01 Apr 2008 - 
TL;DR: Alteplase was non-significantly associated with lower infarct growth and significantly associated with increased reperfusion in patients who had mismatch, and phase III trials beyond 3 h after treatment are warranted.
Journal Article

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Stephen M. Davis, +20 more
- 01 Jan 2008 - 
TL;DR: In this paper, Alteplase was shown to promote reperfusion and attenuate infarct growth in patients who have a mismatch in perfusion-weighted MRI (PWI) and diffusion weighted MRI (DWI).
Journal ArticleDOI

Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome

Tracey A. Baird, +8 more
- 01 Sep 2003 - 
TL;DR: Persistent hyperglycemia on serial glucose monitoring is an independent determinant of infarct expansion and is associated with worse functional outcome and an urgent need to study normalization of blood glucose after stroke.
Journal ArticleDOI

Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target

Ashfaq Shuaib, +4 more
- 01 Oct 2011 - 
TL;DR: Imaging of the brain and vessels has shown that collateral flow can sustain brain tissue for hours after the occlusion of major arteries to the brain, and the augmentation or maintenance of collateral flow is therefore a potential therapeutic target.
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.